| human | Q5 |
| P2798 | Loop ID | 464715 |
| P549 | Mathematics Genealogy Project ID | 137053 |
| P4955 | MR Author ID | 896607 |
| P496 | ORCID iD | 0000-0002-7092-6904 |
| P1153 | Scopus author ID | 15120209000 |
| P1556 | zbMATH author ID | smith.amber-m |
| P184 | doctoral advisor | Frederick R. Adler | Q90467235 |
| P69 | educated at | University of Utah | Q168515 |
| P108 | employer | Los Alamos National Laboratory | Q379848 |
| St. Jude Children's Research Hospital | Q1164246 | ||
| University of Tennessee Health Science Center | Q7896420 | ||
| P734 | family name | Smith | Q1158446 |
| Smith | Q1158446 | ||
| Smith | Q1158446 | ||
| P735 | given name | Amber | Q456808 |
| Amber | Q456808 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | female | Q6581072 |
| P6886 | writing language | English | Q1860 |
| Q33739420 | An accurate two-phase approximate solution to an acute viral infection model |
| Q30400455 | Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics |
| Q64114849 | Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae |
| Q98617077 | Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention |
| Q57232542 | Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling |
| Q30398031 | Influenza A virus infection kinetics: quantitative data and models |
| Q30429002 | Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae |
| Q30428356 | Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses. |
| Q113309198 | Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection |
| Q37733491 | Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza. |
| Q95605531 | Rapid community-driven development of a SARS-CoV-2 tissue simulator |
| Q38229937 | Secondary bacterial infections in influenza virus infection pathogenesis. |
| Q47576940 | The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza |
| Q112558701 | Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration |
| Q91273887 | Validated Models of Immune Response to Virus Infection |
| Q90467235 | Frederick R. Adler | doctoral student | P185 |
Search more.